Details for New Drug Application (NDA): 006325
✉ Email this page to a colleague
NDA 006325 describes TUBOCURARINE CHLORIDE, which is a drug marketed by Bristol Myers Squibb, Hospira, and Lilly, and is included in three NDAs. Additional details are available on the TUBOCURARINE CHLORIDE profile page.
The generic ingredient in TUBOCURARINE CHLORIDE is tubocurarine chloride. There are four drug master file entries for this compound. Additional details are available on the tubocurarine chloride profile page.
The generic ingredient in TUBOCURARINE CHLORIDE is tubocurarine chloride. There are four drug master file entries for this compound. Additional details are available on the tubocurarine chloride profile page.
Summary for 006325
| Tradename: | TUBOCURARINE CHLORIDE |
| Applicant: | Lilly |
| Ingredient: | tubocurarine chloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 006325
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 3MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
